TELA

TELA Bio, Inc.

5.65 USD

Last updated Dec 4, 00:56 UTC

Yesterday HIGH

$5.66

Yesterday LOW

$5.25

52w HIGH

$13.18

52w LOW

$4.23

EPS

-0.45

PE

-12.56

Next Earnings

Mar 19, 2024

Overview News Insider Transactions Government Trades

TELA Bio, Inc. stock is down -2.92% since 30 days ago. The next earnings date is Mar 19, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 4 December’s closed higher than November. 100% of analysts rate it a buy.

TELA Bio, Inc. focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company markets its products through a single direct sales force, principally in the United States.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Medical Equipment

Headquarters

-

Website

telabio.com

Benzinga Newsdesk

Wed Mar 22, 2023

JMP Securities Reiterates Market Outperform on TELA Bio, Maintains $20 Price Target

JMP Securities analyst David Turkaly reiterates TELA Bio (NASDAQ:TELA) with a Market Outperform and maintains $20 price target.
Michael Horton

Tue Mar 21, 2023

TELA Bio Q4 EPS $(0.52) Beats $(0.55) Estimate, Sales $11.62M Miss $13.19M Estimate

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.55) by 5.45 percent. This is a 11.86 percent increase over losses of $(0.59) per share from the same
Benzinga Insights

Tue Mar 21, 2023

Earnings Scheduled For March 21, 2023

Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million.
Benzinga Insights

Mon Mar 20, 2023

Preview: TELA Bio's Earnings
Shanthi Rexaline

Mon Mar 6, 2023

Elon Musk A Frequent Flier In 2022 With Flights Lasting As Little As 13 Minutes, Says Report: His Love For Jet-Setting At Odds With Tesla's Climate Stance?

Tesla Inc. (NASDAQ: TELA) CEO Elon Musk is an entrepreneur who has his fingers in many pies, and undoubtedly time is money for him.
Benzinga Newsdesk

Mon Jan 9, 2023

TELA Bio Announces U.S. Commercial Launch Of NIVIS Fibrillar Collagen Pack, The Natural Restoration Solution To Support Healing Of Surgical Wounds

TELA Bio, Inc. (NASDAQ:TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the
Benzinga Newsdesk

Thu Nov 10, 2022

JMP Securities Maintains Market Outperform on TELA Bio, Lowers Price Target to $20

JMP Securities analyst David Turkaly maintains TELA Bio (NASDAQ:TELA) with a Market Outperform and lowers the price target from $22 to $20.
Lisa Levin

Thu Nov 10, 2022

Coinbase To $80? Plus Deutsche Bank Cuts PT On This Stock By 80%

Citigroup cut the price target on Coinbase Global, Inc. (NASDAQ: COIN) from $105 to $80. Citigroup analyst Peter Christiansen maintained a Buy rating on the stock. Coinbase shares rose 2.1% to $46.95 in pre-market trading.
Benzinga Newsdesk

Thu Nov 10, 2022

Piper Sandler Maintains Overweight on TELA Bio, Lowers Price Target to $15

Piper Sandler analyst Matt O'Brien maintains TELA Bio (NASDAQ:TELA) with a Overweight and lowers the price target from $20 to $15.
Benzinga Newsdesk

Wed Nov 9, 2022

TELA Bio Q3 EPS $(0.64) Misses $(0.63) Estimate, Sales $12.14M Beat $10.86M Estimate

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.63) by 1.59 percent. This is a 12.28 percent decrease over losses of $(0.57) per share from the

JP Morgan

Fri Nov 10, 14:51

buy

confirm

Advanced Data Unlock

Cuca Roberto, COO and CFO

Tue Nov 14, 2023

TELA Recent Insider Trades and Stock Chart

10,000 shares bought
KOBLISH ANTONY, Director

Tue Nov 14, 2023

TELA Recent Insider Trades and Stock Chart

11,000 shares bought